April 02, 2025 11:09 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
In a major boost for tourism, Shimla to get Asia's longest ropeway spanning 13.79 kilometers | Karnataka govt hikes sales tax on diesel, price goes up by Rs. 2 | 'Heard India will be dropping its tariffs substantially': Donald Trump ahead of announcing reciprocal tariff | Opposition MPs decide to vote against Waqf Amendment Bill in Parliament tomorrow | Chilean President Boric visits India, discusses ways to expand bilateral ties with Modi | Himanta Biswa Sarma slams Muhammad Yunus' Northeast remarks, Tripura leader suggests Bangladesh's split | Modi govt determined to uproot Naxalism by March 31, 2026: Amit Shah | Time for reciprocity: White House refers to India's 100 percent tariff imposed on US agri products ahead of April 2 deadline | Fresh encounter breaks out in J&K's Kathua, security forces trap 3 terrorists | Pakistani advocacy group nominates Imran Khan for Nobel Peace Prize
Cervical Cancer Vax
Image Credit: Wallpaper Cave

India's first indigenously developed cervical cancer vaccine launched

| @indiablooms | Sep 02, 2022, at 06:47 am

The Serum Institute of India (SII) and the Department of Biotechnology (DBT) Thursday officially announced India's first indigenous vaccine for cervical cancer.

Union Minister of Science and Technology Jitendra Singh along with SII CEO Adar Poonawalla launched the vaccine at IIC Delhi.

Drugs Controller General of India (DCGI) granted market authorisation for the jibe in July.

As many as 42 lakh women have died due to this disease in India since 2019, according to World Health Organisation (WHO) data. It is the second most frequent cancer among women in the age group between 15 to 44.

The HPV vaccine protects against the types of HPV that most often cause cervical, vaginal, and vulvar cancers.

The vaccine may be priced between Rs 200-400 but it's not finalised yet, SII CEO, Adar Poonawalla said. The company plans to manufacture 200 million doses in 2 years.

The government may launch the vaccine under the National Immunisation programme for 9-14-year-old girls in the next few months.

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.